Advanced search
Publication Cover
International Review of Psychiatry Volume 14, 2002 - Issue 2: Anxiety disorders in children and adolescents
Submit an article Journal homepage
44
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Combining medication and psychosocial treatments: an evidence-based medicine approach

John S. March Child and Family Study Center, Duke University, Durham, North Carolina, USA
Pages 155-163 | Published online: 11 Jul 2009

  • ARNOLD, L.E., ABIKOFF, H.B., CANTWELL, D.P., GONNERS, C.K., ELLIOTT, G., GREENHILL, L.L., HECHTMAN, L, HINSHAW, S.P., HOZA, B., JENSEN, P.S., KRAEMER, H.C., MARCH, J.S., NEWCORN, J.H., PELHAM, W.E., RICHTERS, J.E., SCHILLER, E., SEVERE, J.B., SWANSON, J.M., VERBEN, D. & WELLS, K.C. (1997a). National Institute of Mental Health collaborative multimodal treatment study of children with ADHD (the MTA). Design challenges and choices. Archives of General Psychiatry, 54(9), 865-870.
  • ARNOLD, L.E., ABIKOFF, H.B., CANTWELL, O.P., GONNERS, C.K., ELLIOTT, G., GREENHILL, L.L., HECHTMAN, L, HINSHAW, S.P., HOZA, B., JENSEN, P.S., KRAEMER, H.C., MARCH, J.S., NEWCORN, J.H., PELHAM, W.E., RICHTERS, J.E., SCHILLER, E., SEVERE, J.B., SWANSON, J.M., VERBEN, D. & WELLS, K.C. (1997b). NIMH Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design, methodology and protocol evolution. Journal of Attention Disorders, 2(3), 141-158.
  • BARLOW, D.H., LEVITT, J.T. & BUFKA, L.F. (1999). The dissemination of empirically supported treatments: a view to the future. Behavioral Research Therapy, 37 (Suppl. 1),S147-S162.
  • BARLOW, D.H., GORMAN, J.M., SHEAR, M.K. & WOODS, S.W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder a randomized controlled trial (see comments). JAMA, 283(19), 2529-2536.
  • BERNSTEIN, G.A. & SHAW, K. (1997). Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. American Academy of Child and Adolescent Psychiatry. Journal of the American Academy of Child & Adolescent Psychiatry, 36(Suppl. 10), 69S-84S.
  • BERNSTEIN, G.A., BORCHARDT, C.M. & PERWIEN, A.R. (1996). Anxiety disorders in children and adolescents: a review of the past 10 years. Journal of the American Academy of Child & Adolescent Psychiatry, 35(9), 1110-1119.
  • BERNSTEIN, G.A., WARREN, S.L., MASSIB, E.D. & THURAS, P.D. (1999). Family dimensions in anxiousdepressed school refusers. Journal of Amciety Disorders, 13(5), 513-528.
  • BERNSTEIN, G.A., BORCHARDT, C.M., PERWIEN, A.R., CROSBY, R.D., KUSHNER, M.G., THURAS, P.D. & LAST, C.G. (2000). Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. Journal of the American Academy of Child & Adolescent Psychiatry, 39(3), 276-283.
  • BIRMAHBR, B. (1998). Should we use antidepressant medications for children and adolescents with depressive disorders? Psychopharmacology Bulletin, 34(1), 35-39.
  • BIRMAHER, B., YBLOVICH, A.K. & RENAUD, J. (1998). Pharmacologie treatment for children and adolescents with anxiety disorders. Pediatrie Clinic of North America, 45(5), 1187-1204.
  • BOYLE, M.H. & JADAD, A.R. (1999). Lessons from large trials: the MTA study as a model for evaluating the treatment of childhood psychiatric disorder. Canadian Journal of Psychiatry, 44(10), 991-998.
  • FURUKAWA, T.A. (1999). From effect size into number needed to treat. Lancet, 353(9165), 1680.
  • GLADSTONE, T.R & KASLOW, N.J. (1995). Depression and attributions in children and adolescents: a metaanalytic review. Journal of Abnormal Child Psychology, 23(5), 597-606.
  • GREENHILL, L.L., ABIKOFF, H.B., ARNOLD, L.E., CANTWELL, D.P., GONNERS, C.K., ELLIOTT, G.,HECHTMAN, L., HINSHAW, S.P., HOZA, B., JENSEN, P.S., MARCH, J.S., NEWCORN, J.H., PELHAM, W.E., SEVERE, J.B., SWANSON, J.M., VITIELLO, B. & WELLS, K. (1996). Medication treatment strategies in the MTA study: relevance to clinicians and researchers. Journal of Ae American Academy of Child & Adolescent Psychiatry, 35(10), 1304-1313.
  • GROUP, M.C. (1999a). A 14-month randomized clinical trial of treatment strategies for attention-deficit/ hyperactivity disorder. Multimodal treatment study of children with ADHD [In Process Citation]. Archives of General Psychiatry, 56(12), 1073-1086.
  • GROUP, M.C. (1999b). Moderators and mediators of treatment response for children with attention-deficit/ hyperactivity disorder: the multimodal treatment study of children with attention-deficit/hyperactivity disorder [In Process Citation]. Archives of General Psychiatry, 56(12), 1088-1096.
  • GUYATT, G.H., SACKETT, D.L. & COOK, DJ. (1993). Users' guides to the medical literature. . How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA, 270(21), 2598-2601.
  • GUYATT, G.H., SACKETT, D.L. & COOK, DJ. (1994). Users' guides to the medical literature. . How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA, 271(1), 59-63.
  • GUYATT, G.H., SINCLAIR, J., COOK, DJ. & GLASZIOU, P. (1999). Users' guides to the medical literature: XVI. How to use a treatment recommendation. EvidenceBased Medicine Working Group and the Cochrane Applicability Methods Working Group. JAMA, 281(19), 1836-1843.
  • GUYATT, G.H., JUNIPER, E.F., WALTER, S.D., GRIFFTTH, LE. & GOLDSTEIN, R.S. (1998). Interpreting treatment effects in randomised trials. British Medical Journal, 316(7132), 690-693.
  • GUYATT, G.H., MEADE, M.O., JAESCHKE, R.Z., COOK, DJ. & HAYNES, R.B. (2000a). Practitioners of evidence based care. Not all clinicians need to appraise evidence from scratch but all need some skills (editorial). British Medical Journal, 520(7240), 954-955.
  • GUYATT, G.H., HAYNES, R.B., JAESCHKE, R.Z., COOK, DJ., GREEN, L., NAYLOR, C.D., WILSON, M.C. & RICHARDSON, W.S. (200Ob). Users' guides to the medical literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. JAMA, 284(10), 1290-1296.
  • HAYES, S. (1981). Single case experimental design and empirical clinical practice. Journal of Consulting and Clinical Psychology, 49,193-211.
  • HINSHAW, S.P., MARCH, J.S., ABIKOFF, H.B., ARNOLD, L.E., CANTWELL, D., CONNERS, C., ELLIOTT, G., GREENHILL, L.L., HALPERIN, J., HECHTMAN, L., HOZA, B., JENSEN, P., MARCH, J., NEWCORN, J., PELHAM, W., RICHTERS, J., SEVERE, J.B., SCHILLER, E., SWANSON, J., VEEREN, D., WELLS, K. & WIGAL, T. (1997). Comprehensive assssment of childhood attention-deficit hyperactivity disorder in the context of a miltisite, multimodal clinical trial. Journal of Attention Disorders, 1 (4), 217-234.
  • JENSEN, P.S., HINSHAW, S.P., SWANSON, J.M., GREENHILL, LL., CONNERS, C.K., ARNOLD, L.E., ABIKOFF, H.B., ELLIOTT, G., HECHTMAN, L., HOZA, B., MARCH, J.S., NEWCORN, J.H., SEVERE, J.B., VTTIELLO, B., WELLS, K. & WIGAL, T. (2001). Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary careproviders. Journal of Developmental and Behavioral Pediatrics, 22, 60-73.
  • JENSEN, P.S. (1999). Fact versus fcncy concerning the multimodal treatment study for attention-deficit hyperactivity disorder. Canadian Journal of Psychiatry, 44(1O), 975-980.
  • JENSEN, P.S., MARTIN, D. & CANTWELL, O.P. (1997). Comorbidity in ADHD: implications for research, practice, and DSM-V. Journal of the American Academy of Chad & Adolescent Psychiatry, 36(8), 1065-1079.
  • KAZDIN, A.E. (1997). A model for developing effective treatments: progression and interplay of theory, research, and practice. Journal of Clinical Chad Psychology, 26(2), 114-129.
  • KRATOCHVIL, C., KSUTCHER, S., REITER, S. & MARCH, J. (1999). Pharmacotherapy of pediatric anxiety disorders. In: S. Russ & T. OLLENDICK (Eds), Handbook of psychotherapies with children and families (pp. 345-366). New York Plenum.
  • LEONARD, H.L., MARCH, J., RICKLER, K.C. & ALLEN, A.J. (1997). Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 36(6), 725-736.
  • LEVINE, M., WALTER, S., LEE, H., HAINES, T., HOLBROOK, A. & MOVER, V. (1994). Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA, 271(20), 1615-1619.
  • LUDWIG, A.M. & OTHMER, K. (1977). The medical basis of psychiatry. American Journal of Psychiatry, 134(10), 1087-1092.
  • MARCH, J. (1998). Cognitive behavioral psychotherapy for pdiatrie OCD. In: M. JENIKE, L. BAER & W. MINICHELLO (Eds), Obsessive-compulsive disorders (3rd ed., pp. 400-420). Philadelphia, PN: Mosby.
  • MARCH, J. (1999). Current status of pharmacotherapy for pediatrie anxiety disorders. In: D. BEIDEL (Ed.), Treating anxiety disorders in youth: current problems and future solutions (ADAAINIMH) (pp. 42-62). Washington, DC: Anxiety Disorders Association of America.
  • MARCH, J. (2000). Child psychiatry: cognitive and behavior therapies. In: B. SADDOCK & V. SADDOCK (Eds), Comprehensive textbook of psychiatry/VII (pp. 2806-2812). New York: Williams and Wilkins.
  • MARCH, J., FRANCES, A., KAHN, D. & CARPENTER, D. (1997). Expert consensus guidelines: treatment of obsessive-compulsive disorder. Journal of Clinical Psychiatry, 5S(Suppl. 4), 1-72.
  • MARCH, J.S. & CURRY, J.F. (1998). Predicting the outcome of treatment. Journal of Abnormal Chad Psychology, 26(1), 39-51.
  • MARCH, J.S. & LEONARD, H.L. (1998). OCD in children: research and treatment. In: R. SWINSON, J. RACHMAN, M. ANTONY & M. RICHTER (Eds), Obsessive-compulsivedisorder: theory, research, and treatment (pp. 367-394). New York Guilford.
  • MARCH, J.S., BIEDERMAN, J., WOLKOW, R., SAFFERMAN, A., MARDEKIAN, J., COOK, E.H., CUTLER, N.R., DOMINGUEZ, R., FERGUSON, J., MULLER, B., RIESENBERG, R., ROSENTHAL, M., SALLEE, F.R. & WAGNER, K.D. (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial (see comments). JAMA, 280(20), 1752-1756.
  • MARCH, J.S., SWANSON, J.M., ARNOLD, L.E., HOZA, B., CONNERS, C.K., HINSHAW, S.P., HECHTMAN, L., KRAEMER, H.C., GREENHILL, L.L., ABIKOFF, H.B., ELLIOTT, KG., JENSEN, P.S., NEWCORN, J.H., VITIRELLO, B., SEVERE, J., WELLS, K.C. & PELHAM, W.E. (2000). Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). Journal of Abnormal Child Psychology, 28(6), 527-541.
  • NORQUIST, O.S. & MAGRUDER, K.M. (1998). Views from funding agencies. National Institute of Mental Health. Medical Care, 36(9), 1306-1308.
  • PLISZKA, S. (1998). Comorbidity of attention-deficit/ hyperactivity disorder with psychiatric disorder an overview. Journal of Clinical Psychiatry, 59(Suppl. 7), 50-58.
  • RUPP (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344(17), 1279-1285.
  • SACKETT, D., RICHARDSON, W., ROSENBERG, W. & HAYNES, B. (2000). Evidence-based medicine (2nd ed.). London: Churchill Livingston.
  • SWANSON, J. (1993). Effect of stimulant medication on hyperactive children: a review of reviews. Exceptional Child, 60, 154-162.
  • TURNER, S. & HEISER, N. (1999). Current status of psychological interventions for childhood anxiety disorders. In: D. BEIDEL (Ed.), Treating anxiety disorders in youth: current problems and future solutions (ADAAI NIMH) (pp. 63-76). Washington, DC: Anxiety Disorders Association of America.
  • WEISZ, J.R. (2000). Agenda for child and adolescent psychotherapy research: on the need to put science into practice (comment). Archives of General Psychiatry, 57(9), 837-S38.
  • WELLS, K.C., PELHAM, W.E., JR, KOTKIN, R.A., HOZA, B., ABIKOFF, H.B., ABRAMOWITZ, A., ARNOLD, L.E., CANTWELL, O.P., CONNERS, C.K., DEL CARMEN, R., ELLIOTT, G., GREENHILL, L.L., HECHTMAN, L., HIBBS, E., HINSHAW, S.P., JENSEN, P.S., MARCH, J.S., SWANSON, J.M. & SCHILLER, E. (2000). Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. Journal of Abnormal Child Psychology, 28(6), 483-505.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.